Electra Therapeutics Inc., a clinical-stage developer of immunology drugs, opened at its IPO price on Friday after raising $350 million in an upsized US offering.
View SourceElectra Therapeutics Inc., a clinical-stage developer of immunology drugs, opened at its IPO price on Friday after raising $350 million in an upsized US offering.
View Source